Intelligence · Drug directory
Rare Disease Drugs Directory
Orphan and rare disease therapies, enzyme replacements, and gene therapies for ultra-rare indications.
Quick answer
Rare disease drugs: NovaPharmaNews indexes 5 pharmaceutical drugs in this therapeutic segment with regulatory status, pipeline programs, patents, and congress coverage cross-links. Orphan and rare disease therapies, enzyme replacements, and gene therapies for ultra-rare indications.
-
dextromethorphan hydrobromide
NUEDEXTA Amneal Pharma Europe Ltd
N07XX59 -
dextromethorphan polistirex
DEXTROMETHORPHAN POLISTIREX Amneal Pharma Europe Ltd
-
butorphanol tartrate
BUTORPHANOL TARTRATE
-
levallorphan tartrate
LORFAN
-
levorphanol tartrate
LEVO-DROMORAN
Frequently asked questions
How many rare disease drugs are in the directory?
5 drug profiles match this therapeutic area filter based on class, mechanism, target, and INN metadata.
How are drugs assigned to a therapeutic area?
Classification uses WHO therapeutic class, mechanism of action, molecular target, and INN pattern matching against curated oncology, metabolic, CNS, rare disease, and immunology taxonomies.